CMIC HOLDINGS Co., Ltd. alternatives
Companies similar to CMIC HOLDINGS Co., Ltd. on cdmo.directory, ranked by shared capabilities and locations focusing on Clinical Trial Services, China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, and EU EMA Regulatory Strategy. Below are the top 10 cdmos with overlapping structured profile data.
Shares Clinical Trial Services, Regulatory Affairs, Clinical Operations, and Phase IV / Post-Marketing.
Shares EU EMA Regulatory Strategy, US FDA Regulatory Strategy, and Regulatory Affairs.
Shares Clinical Trial Services, Regulatory Affairs, Clinical Operations, and Phase IV / Post-Marketing.
Shares Clinical Trial Services, China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, and EU EMA Regulatory Strategy.
Shares Clinical Trial Services, China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, and EU EMA Regulatory Strategy.
Shares Phase I Clinical Trials.
Shares China NMPA Regulatory Strategy, EU EMA Regulatory Strategy, and US FDA Regulatory Strategy.
Shares Clinical Trial Services, Regulatory Affairs, Clinical Operations, and Phase II Clinical Trials.
Shares Clinical Trial Services.
Shares US FDA Regulatory Strategy and Regulatory Affairs.
How we pick similar companies: alternatives similarity uses shared services, modalities, locations, and site-specific capability fields — not sponsorship. Missing fields stay blank. Data comes from structured directory profiles.
← Back to CMIC HOLDINGS Co., Ltd. profile
Interactive comparison
Lock shared capabilities to filter peers. Locked views are not indexed — the canonical page stays unlocked.
Capability locks
- Lambda Therapeutic Research
Shares Clinical Trial Services, Regulatory Affairs, Clinical Operations, and Phase IV / Post-Marketing.
- Viralgen
Shares EU EMA Regulatory Strategy, US FDA Regulatory Strategy, and Regulatory Affairs.
- Altasciences
Shares Clinical Trial Services, Regulatory Affairs, Clinical Operations, and Phase IV / Post-Marketing.
- Syngene International
Shares Clinical Trial Services, China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, and EU EMA Regulatory Strategy.
- Pharmaron
Shares Clinical Trial Services, China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, and EU EMA Regulatory Strategy.
- Eurofins Central Laboratory
Shares Phase I Clinical Trials.
- uBriGene
Shares China NMPA Regulatory Strategy, EU EMA Regulatory Strategy, and US FDA Regulatory Strategy.
- Nuvisan
Shares Clinical Trial Services, Regulatory Affairs, Clinical Operations, and Phase II Clinical Trials.
- Esco Aster
Shares Clinical Trial Services.
- ResolveMass Laboratories Inc.
Shares US FDA Regulatory Strategy and Regulatory Affairs.
Markdown mirror: /alternatives/cmicgroup.md